Home›Research›Compare›Angiotensin (1-7) vs MOTS-c
Peptide ComparisonAngiotensin (1-7) vs MOTS-c
Both are Longevity & Cellular peptides.
Angiotensin (1-7)
Ang-(1-7)
Half-life: ~9–10 sec (rat)
No providers listed yet
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
Half-life: Unknown (rapidly cleared from plasma)
181 providers listed
Angiotensin (1-7) carries stronger published evidence (RCT, 15 key studies) than MOTS-c (Cohort study, 19); both are research compounds.
Angiotensin (1-7)
Evidence
Half-life
~9–10 sec (rat)
MOTS-c
Evidence
Half-life
Unknown (rapidly cleared from plasma)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Angiotensin (1-7) |
| Further along in FDA review | Angiotensin (1-7) |
| More provider options (0 vs 181) | MOTS-c |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Angiotensin (1-7)
MOTS-c
Angiotensin (1-7)
The Effect of Angiotensin (1-7) on Serum Metabolomics in Obese Type 2 Diabetic Mice.
Perioperative Angiotensin-(1-7) for Postoperative Cognitive Vulnerability Following Coronary Artery Bypass Su…
Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE Inhibitor.
Neuroprotective effects of telmisartan in a harmaline-induced model of essential tremor: modulation of the re…
+11 more
MOTS-c
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resis…
LAT1-mediated delivery of engineered R13A-MOTS-c attenuates radiation-induced lung injury via Nrf2 activation…
Circulating mitochondrial-derived microproteins at rest and in response to an acute bout of endurance exercis…
Mitochondrial-derived peptide MOTS-c activates metabolic signaling but blunts reparative function in human me…
+15 more
About Angiotensin (1-7)
Binds Mas receptor (MasR), activating nitric oxide synthase and reducing oxidative stress. Opposes TGF-β and angiotensin II signaling to reduce fibrosis. Enhances insulin sensitivity and provides cardiovascular protection.
About MOTS-c
Mitochondria-derived peptide that translocates to nucleus under stress; activates AMPK pathway, regulates AICAR and folate-methionine cycle
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Angiotensin (1-7)
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
MOTS-c
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Angiotensin (1-7)
Not enough vendor pricing yet.
MOTS-c
Where to source these peptides
Angiotensin (1-7)
Browse directory →
Providers offeringMOTS-c
181 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Angiotensin (1-7) vs MOTS-c — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/angiotensin-1-7/mots-c